Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1993
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil ; day:15 ; month:9 ; year:2020 ; pages:1-8
Pharmaceutical medicine ; (15.9.2020), 1-8
- Creator
-
Vogler, Marcelo
Ricci Conesa, Heloísa
Araújo Ferreira, Karla de
Moreira Cruz, Flávia
Simioni Gasparotto, Fernanda
Fleck, Karen
Maciel Rebelo, Fernanda
Kollross, Bianca
Silveira Gonçalves, Yannie
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40290-020-00349-6
- URN
-
urn:nbn:de:101:1-2020110319111803787387
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vogler, Marcelo
- Ricci Conesa, Heloísa
- Araújo Ferreira, Karla de
- Moreira Cruz, Flávia
- Simioni Gasparotto, Fernanda
- Fleck, Karen
- Maciel Rebelo, Fernanda
- Kollross, Bianca
- Silveira Gonçalves, Yannie
- SpringerLink (Online service)
Other Objects (12)
Governance and pharmacovigilance in Brazil: a scoping review
Statistical methods for pharmacovigilance based on electronic healthcare data
Pharmacovigilance in the European Union : practical implementation across member states
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
Pharmacovigilance in oncology
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Enhancing the reporting of implementation research
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Governance and pharmacovigilance in Brazil: a scoping review
Statistical methods for pharmacovigilance based on electronic healthcare data
Pharmacovigilance in the European Union : practical implementation across member states
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
Pharmacovigilance in oncology
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Enhancing the reporting of implementation research
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Governance and pharmacovigilance in Brazil: a scoping review
Statistical methods for pharmacovigilance based on electronic healthcare data
Pharmacovigilance in the European Union : practical implementation across member states
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
Pharmacovigilance in oncology
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Enhancing the reporting of implementation research
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib